Tapewire

Nasdaq · USD

QTTB

Q32 Bio Inc.

Export transactions ↓
Tapewire entity
5594
SEC CIK
0001661998
Parsed reports
295

Last 12 months

Inside the activity.

4 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202600
Feb 202603
Mar 202600
Apr 202600
May 202640
Jun 202600
Jul 202600
Aug 202603
Sep 202600
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 25, 2024 Filed Mar 27, 2024 21:25 UTC GrantStock Option (Right to Buy) · Derivative 12,767 $0.00 Strike: $16.82 $0.00
Disclosure

SEC source: 0000950170-24-037368 · ownership.xml · derivative · entry 1

Lundberg Sven Ante · CIK 0001682126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,767

Underlying: Common Stock · 12,767 shares

Expires 2034-03-24

F1 · derivative.exercise_date: One-third of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 20:15 UTC
Alloway PaulSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 18,090 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-037197 · ownership.xml · derivative · entry 3

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,090 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 20:15 UTC
Alloway PaulSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 5,440 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-037197 · ownership.xml · derivative · entry 2

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,440 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 20:15 UTC
Alloway PaulSee Remarks
Exercise / conversionCommon Stock 23,530 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-037197 · ownership.xml · nonDerivative · entry 1

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,566

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 20:15 UTC Exercise / conversionRestricted Stock Units · Derivative 5,360 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-037196 · ownership.xml · derivative · entry 3

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,360 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 20:15 UTC Exercise / conversionRestricted Stock Units · Derivative 1,088 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-037196 · ownership.xml · derivative · entry 2

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,088 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 20:15 UTC Exercise / conversionCommon Stock 6,448 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-037196 · ownership.xml · nonDerivative · entry 1

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,046

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
March 25, 2024 Filed Apr 23, 2024 21:03 UTC
Alloway PaulSee Remarks
SaleCommon Stock 268 $24.21 $6,488.28
Disclosure

SEC source: 0000950170-24-047031 · ownership.xml · nonDerivative · entry 1

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,596

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs.

F2 · shares: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.

F2 · balance_after: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.

Read SEC document
March 25, 2024 Filed Apr 23, 2024 21:00 UTC SaleCommon Stock 75 $24.20 $1,815.00
Disclosure

SEC source: 0000950170-24-047018 · ownership.xml · nonDerivative · entry 1

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 927

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs.

F2 · shares: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.

F2 · balance_after: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.

Read SEC document
March 25, 2024 Filed Aug 14, 2024 20:05 UTC Exercise / conversionRestricted Stock Units · Derivative 1,095 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-096986 · ownership.xml · derivative · entry 3

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,095 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock.

F2 · shares: The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split.

F4 · derivative.exercise_date: The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date.

F4 · derivative.expiration_date: The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date.

Read SEC document
March 25, 2024 Filed Aug 14, 2024 20:05 UTC SaleCommon Stock 265 $24.20 $6,413.00
Disclosure

SEC source: 0000950170-24-096986 · ownership.xml · nonDerivative · entry 2

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,983

F3 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.

Read SEC document
March 25, 2024 Filed Aug 14, 2024 20:05 UTC Exercise / conversionCommon Stock 1,095 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-096986 · ownership.xml · nonDerivative · entry 1

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,248

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock.

F2 · balance_after: The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split.

Read SEC document
January 09, 2024 Filed Feb 15, 2024 21:33 UTC SaleCommon Stock 13,037 $0.57 $7,445.43
Disclosure

SEC source: 0000950170-24-015944 · ownership.xml · nonDerivative · entry 3

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,778

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5710 to $0.5712. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:54 UTC
Alloway PaulSee Remarks
SaleCommon Stock 7,280 $0.57 $4,120.48
Disclosure

SEC source: 0000950170-24-002572 · ownership.xml · nonDerivative · entry 1

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,036

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.

F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.058 to $0.58. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:49 UTC SaleCommon Stock 1,708 $0.57 $975.27
Disclosure

SEC source: 0000950170-24-002563 · ownership.xml · nonDerivative · entry 1

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,598

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.

F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.571 to $0.584. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC
Alloway PaulSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 8,910 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 6

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,090

Underlying: Common Stock · 8,910 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date.

F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC
Alloway PaulSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 5,280 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 5

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,440

Underlying: Common Stock · 5,280 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.

F3 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC
Alloway PaulSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 4,420 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 4

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,420 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The RSUs have vested and settled in full on January 1, 2024. The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs have vested and settled in full on January 1, 2024. The RSUs do not have an expiration date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC
Alloway PaulSee Remarks
Exercise / conversionCommon Stock 8,910 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 3

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,316

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC
Alloway PaulSee Remarks
Exercise / conversionCommon Stock 5,280 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 2

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,406

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC
Alloway PaulSee Remarks
Exercise / conversionCommon Stock 4,420 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 1

Alloway Paul · CIK 0001916155 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,126

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC Exercise / conversionRestricted Stock Units · Derivative 2,640 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000907 · ownership.xml · derivative · entry 6

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,360

Underlying: Common Stock · 2,640 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date.

F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC Exercise / conversionRestricted Stock Units · Derivative 1,056 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000907 · ownership.xml · derivative · entry 5

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,088

Underlying: Common Stock · 1,056 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle as to 1,056 shares on January 1, 2024 and 1,008 shares on January 1, 2025. The RSUs do not have an expiration date.

F3 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle as to 1,056 shares on January 1, 2024 and 1,008 shares on January 1, 2025. The RSUs do not have an expiration date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC Exercise / conversionRestricted Stock Units · Derivative 544 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000907 · ownership.xml · derivative · entry 4

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 544 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: The RSUs vested and settled in full on January 1, 2024. The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs vested and settled in full on January 1, 2024. The RSUs do not have an expiration date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC Exercise / conversionCommon Stock 2,640 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-000907 · ownership.xml · nonDerivative · entry 3

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC Exercise / conversionCommon Stock 1,056 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-000907 · ownership.xml · nonDerivative · entry 2

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:15 UTC Exercise / conversionCommon Stock 544 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-000907 · ownership.xml · nonDerivative · entry 1

Michaud Charles Jr · CIK 0001999011 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2024 Filed Feb 15, 2024 21:33 UTC Exercise / conversionRestricted Stock Units · Derivative 19,140 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-015944 · ownership.xml · derivative · entry 5

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,720

Underlying: Common Stock · 19,140 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.

F5 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.

Read SEC document
January 01, 2024 Filed Feb 15, 2024 21:33 UTC Exercise / conversionRestricted Stock Units · Derivative 14,280 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-015944 · ownership.xml · derivative · entry 4

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,280 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs are fully vested and do not have an expiration date.

F4 · derivative.expiration_date: The RSUs are fully vested and do not have an expiration date.

Read SEC document
January 01, 2024 Filed Feb 15, 2024 21:33 UTC Exercise / conversionCommon Stock 19,140 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-015944 · ownership.xml · nonDerivative · entry 2

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2024 Filed Feb 15, 2024 21:33 UTC Exercise / conversionCommon Stock 14,280 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-015944 · ownership.xml · nonDerivative · entry 1

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,675

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:44 UTC
Seymour AlbertDirector · See Remarks
Exercise / conversionRestricted Stock Units · Derivative 4,620 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-047302 · ownership.xml · derivative · entry 3

Seymour Albert · CIK 0001735324 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,380

Underlying: Common Stock · 4,620 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The RSUs will vest and settle as to one third of the RSUs on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025. The RSUs have no expiration date.

F3 · derivative.expiration_date: The RSUs will vest and settle as to one third of the RSUs on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025. The RSUs have no expiration date.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:44 UTC
Seymour AlbertDirector · See Remarks
SaleCommon Stock 1,448 $1.15 $1,665.49
Disclosure

SEC source: 0000950170-23-047302 · ownership.xml · nonDerivative · entry 2

Seymour Albert · CIK 0001735324 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,874

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:44 UTC
Seymour AlbertDirector · See Remarks
Exercise / conversionCommon Stock 4,620 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-047302 · ownership.xml · nonDerivative · entry 1

Seymour Albert · CIK 0001735324 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 152,322

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 4,644 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · derivative · entry 9

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,644 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F5 · derivative.exercise_date: Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such restricted stock units would have become fully vested on January 1, 2026. The remaining restricted stock units have been automatically cancelled and forfeited.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 387 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · derivative · entry 8

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 387 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F4 · derivative.exercise_date: Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,548 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · derivative · entry 7

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,548 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F4 · derivative.exercise_date: Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
SaleCommon Stock 1,308 $1.39 $1,818.12
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 6

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,496

F3 · shares: The sales reported in the Form 4 were effected pursuant to a mandatory sell to cover arrangement solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
Exercise / conversionCommon Stock 4,644 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 5

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,804

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
SaleCommon Stock 109 $1.39 $151.51
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 4

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,160

F2 · shares: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
Exercise / conversionCommon Stock 387 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 3

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
SaleCommon Stock 436 $1.39 $606.04
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 2

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,882

F2 · shares: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
August 03, 2023 Filed Aug 8, 2023 01:39 UTC
Jordan JulieChief Medical Officer
Exercise / conversionCommon Stock 1,548 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-039299 · ownership.xml · nonDerivative · entry 1

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:08 UTC
Jordan JulieChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 350 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-038564 · ownership.xml · derivative · entry 3

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F3 · derivative.exercise_date: The restricted stock units vested and settled in full on August 2, 2023.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:08 UTC
Jordan JulieChief Medical Officer
SaleCommon Stock 99 $1.31 $129.69
Disclosure

SEC source: 0000950170-23-038564 · ownership.xml · nonDerivative · entry 2

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,770

F2 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on September 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:08 UTC
Jordan JulieChief Medical Officer
Exercise / conversionCommon Stock 350 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-038564 · ownership.xml · nonDerivative · entry 1

Jordan Julie · CIK 0001968554 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,869

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
June 14, 2023 Filed Jun 15, 2023 22:09 UTC GrantOption (Right to Buy) · Derivative 23,000 $0.00 Strike: $1.03 $0.00
Disclosure

SEC source: 0000950170-23-028383 · ownership.xml · derivative · entry 1

Poulton Jeffrey V. · CIK 0001782962 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 14, 2023 Filed Jun 15, 2023 18:33 UTC GrantOption (Right to Buy) · Derivative 23,000 $0.00 Strike: $1.03 $0.00
Disclosure

SEC source: 0000950170-23-028411 · ownership.xml · derivative · entry 1

Patterson Matthew R · CIK 0001401018 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 14, 2023 Filed Jun 15, 2023 23:25 UTC GrantOption (Right to Buy) · Derivative 23,000 $0.00 Strike: $1.03 $0.00
Disclosure

SEC source: 0000950170-23-028428 · ownership.xml · derivative · entry 1

GILLIS STEVEN · CIK 0001229592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2023-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 14, 2023 Filed Jun 15, 2023 22:17 UTC
Thistle MaryDirector
GrantOption (Right to Buy) · Derivative 23,000 $0.00 Strike: $1.03 $0.00
Disclosure

SEC source: 0000950170-23-028396 · ownership.xml · derivative · entry 1

Thistle Mary · CIK 0001317917 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 14, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.